Treatment of active lupus nephritis with the novel immunosuppressant 15-deoxyspergualin: an open-label dose escalation study

INTRODUCTION: As the immunosuppressive potency of 15-deoxyspergualin (DSG) has been shown in the therapy of renal transplant rejection and Wegener's granulomatosis, the intention of this study was to evaluate the safety of DSG in the therapy of lupus nephritis (LN). METHODS: Patients with histo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Lorenz, Hanns-Martin, Schmitt, Wilhelm H, Tesar, Vladimir, Müller-Ladner, Ulf, Tarner, Ingo, Hauser, Ingeborg A, Hiepe, Falk, Alexander, Tobias, Woehling, Heike, Nemoto, Kyuichi, Heinzel, Peter A
Format: Artigo
Sprache:Inglês
Veröffentlicht: BioMed Central 2011
Schlagworte:
Research Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3132014/
https://ncbi.nlm.nih.gov/pubmed/21356124
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/ar3268
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge